Literature DB >> 31180607

Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis.

Emily Stockings1, Lucy Thi Tran1, Thomas Santo1, Amy Peacock1, Sarah Larney1, Damian Santomauro2, Michael Farrell1, Louisa Degenhardt1.   

Abstract

BACKGROUND AND AIMS: Amphetamines are the second most commonly used class of illicit drugs. We aimed to produce pooled estimates of mortality risks among people with regular or dependent use of amphetamines, with a focus upon all-cause mortality as well as specific causes of death.
DESIGN: Systematic review and meta-analysis of cohorts of people with problematic use or dependence on amphetamines with data on all-cause or cause-specific mortality. SETTING AND PARTICIPANTS: Of 4240 papers, 30 were eligible, reporting on 25 cohorts that measured all-cause mortality, drug poisoning, suicide, accidental injuries, homicide and cardiovascular mortality. Cohorts (n = 35-74 139) were in North America, several Nordic countries and Asia Pacific. MEASUREMENT: Titles/abstracts were independently screened by one reviewer and excluded those reviewed by a second reviewer. Full-text screening was by two reviewers with discrepancies resolved via a third reviewer. We extracted data on crude mortality rates (CMR) per 100 person-years (py), standardized mortality ratios (SMRs). We imputed SMRs where possible if not reported by study authors. We also calculated mortality relative risks. Data were pooled using random-effects models; potential reasons for heterogeneity were explored using subgroup analyses and meta-regressions.
FINDINGS: Twenty-three cohorts contributed data for the pooled all-cause CMR: 1.14 per 100 py [95% confidence interval (CI) = 0.92-1.42]. Pooled cause-specific mortality rates were: drug poisoning, 0.14 per 100 py (95% CI = 0.06-0.34); cardiovascular disease, 0.13 per 100 py (95% CI = 0.06-0.29); suicide, 0.20 per 100 py (95% CI = 0.07-0.55); accidental injury, 0.20 per 100 py (95% CI = 0.08-0.47) and homicide, 0.03 per 100 py (95% CI = 0.02-0.06). There was substantial heterogeneity for all pooled CMR estimates except homicide. The pooled all-cause SMR was 6.83 (95% CI = 5.27-8.84). Pooled cause-specific SMRS were: poisoning, 24.70 (95% CI = 16.67, 36.58); homicide, 11.90 (95% CI = 7.82-18.12); suicide, 12.20 (95% CI = 4.89-30.47); cardiovascular disease, 5.12 (95% CI = 3.74-7.00) and accidental injury, 5.12 (95% CI = 2.88-9.08).
CONCLUSIONS: People with regular or dependent amphetamine use are at elevated risk of a range of causes of mortality compared with people without regular or dependent amphetamine use.
© 2019 Society for the Study of Addiction.

Entities:  

Keywords:  Amphetamines; cohort studies; meta-analysis; mortality; stimulants; systematic review

Mesh:

Substances:

Year:  2019        PMID: 31180607      PMCID: PMC6732053          DOI: 10.1111/add.14706

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  39 in total

1.  Psychiatric severity and mortality in substance abusers: a 15-year follow-up of drug users.

Authors:  Mats Fridell; M Hesse
Journal:  Addict Behav       Date:  2005-06-20       Impact factor: 3.913

2.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  Lancet       Date:  2007-10-20       Impact factor: 79.321

Review 3.  Mortality among amphetamine users: a systematic review of cohort studies.

Authors:  Jessica Singleton; Louisa Degenhardt; Wayne Hall; Tomas Zabransky
Journal:  Drug Alcohol Depend       Date:  2009-07-23       Impact factor: 4.492

Review 4.  Major physical and psychological harms of methamphetamine use.

Authors:  Shane Darke; Sharlene Kaye; Rebecca McKetin; Johan Duflou
Journal:  Drug Alcohol Rev       Date:  2008-05

5.  Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand.

Authors:  Vu Minh Quan; Tasanai Vongchak; Jaroon Jittiwutikarn; Surinda Kawichai; Namtip Srirak; Kanokporn Wiboonnatakul; Myat Htoo Razak; Vinai Suriyanon; David D Celentano
Journal:  Addiction       Date:  2007-03       Impact factor: 6.526

6.  Outcome of drug abuse in a 20-year follow-up study of drug-experimenting schoolchildren in Finland.

Authors:  P Turpeinen
Journal:  Nord J Psychiatry       Date:  2001       Impact factor: 2.202

7.  Mortality in a cohort of opiate and amphetamine users in Perth, Western Australia.

Authors:  Anne Bartu; Nerelie C Freeman; Geoff S Gawthorne; James P Codde; C D'Arcy J Holman
Journal:  Addiction       Date:  2004-01       Impact factor: 6.526

8.  Mortality risk among recent-onset injection drug users in five U.S. cities.

Authors:  David Vlahov; Cunlin Wang; Danielle Ompad; Crystal M Fuller; Wendy Caceres; Lawrence Ouellet; Peter Kerndt; Don C Des Jarlais; Richard S Garfein
Journal:  Subst Use Misuse       Date:  2008       Impact factor: 2.164

Review 9.  Methamphetamine and cardiovascular pathology: a review of the evidence.

Authors:  Sharlene Kaye; Rebecca McKetin; Johan Duflou; Shane Darke
Journal:  Addiction       Date:  2007-06-12       Impact factor: 6.526

10.  Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.

Authors:  Rebecca McKetin; Erin Kelly
Journal:  Drug Alcohol Rev       Date:  2007-03
View more
  3 in total

Review 1.  Cerebrovascular and cardiovascular diseases caused by drugs of abuse.

Authors:  Yuichi Akasaki; Mitsuru Ohishi
Journal:  Hypertens Res       Date:  2019-12-05       Impact factor: 3.872

2.  Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study.

Authors:  Annick Bórquez; Katherine Rich; Michael Farrell; Louisa Degenhardt; Rebecca McKetin; Lucy T Tran; Javier Cepeda; Alfonso Silva-Santisteban; Kelika Konda; Carlos F Cáceres; Sherrie Kelly; Frederick L Altice; Natasha K Martin
Journal:  J Int AIDS Soc       Date:  2020-06       Impact factor: 5.396

Review 3.  Responding to global stimulant use: challenges and opportunities.

Authors:  Michael Farrell; Natasha K Martin; Emily Stockings; Annick Bórquez; Javier A Cepeda; Louisa Degenhardt; Robert Ali; Lucy Thi Tran; Jürgen Rehm; Marta Torrens; Steve Shoptaw; Rebecca McKetin
Journal:  Lancet       Date:  2019-10-23       Impact factor: 79.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.